Across TCGA pan-cancer cohorts, RNU6-811P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-811P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-811P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-811P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, LIHC, and KICH are the cancer types where RNU6-811P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.202	0.561	.001	126	view →
LIHC	OS	Tertile	All	0.135	0.786	<.001	108	view →
KICH	DFS	Tertile	All	0.035	0.900	<.001	54	view →
ESCA	DFS	Tertile	III,IV	1.000	0.281	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-811P tumor-vs-normal RNA expression · all RNU6-811P data types